With the election behind us and immense government public health reform on the horizon, the study by Rogers et al, titled COVID-19 Vaccines: A Risk Factor for Cerebral Thrombotic Syndromes, was just published after successful peer-review in the International Journal of Innovative Research in Medical Science.
The methodology employed for this study is as follows:
Data were collected from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) Vaccine Adverse Event Reporting System (VAERS) database from January 1, 1990 to December 31, 2023. CTE AEs (cerebral thromboembolism adverse events) after COVID-19 vaccines were compared to those after influenza vaccines and after all other vaccines using proportional reporting ratio (PRR) analysis by time.
They found that brain clots (cerebral thromboembolism adverse events) are 112,000% more likely to occur after receiving a COVID-19 vaccine than after receiving an influenza vaccine. When comparing COVID-19 vaccines to all other vaccines combined, the likelihood is 20,700% higher. After COVID-19 vaccination, there were 5,137 reported cases of cerebral thromboembolism in just 3 years (36 months). For influenza vaccines over the past 34 years (408 months), there were only 52 reported cases.
Hellbound and Down 